The accurate analysis of trace component in complex biological matrices requires the use of reliable standards. For liquid chromatography/mass spectrometry analysis, the stable isotope-labeled derivatives of the analyte molecules are the most appropriate internal standards. We report here the synthesis of (2β,3α,6-2 H 3 )cholesteryl linoleate and oleate containing three non-exchangeable deuterium in the steroid ring. The principal reactions used were: (1) trans diaxial opening of 2α,3α-epoxy-6-oxo-5α-cholestane with LiAlD 4 and subsequent oxidation of the resulting (2β,6α-2 H 2 )-3α,6β-diol with Jones' reagent, followed by reduction of the resulting (2β-2 H)-3,6-dione with NaBD 4 leading to the (2β,3α,6α-2 H 3 )-3β,6β-dihydroxy-5α-cholestane, (2) selective protection of the 3β-hydroxy group as the tert-butyldimethylsilyl ether, (3) dehydration of the 6β-hydroxy group with POCl 3 and removal of tert-butyldimethylsilyloxy groups with 5M HCl in acetone, and (4) esterification of the resultant (2β,3α,6-2 H 3 )cholesterol with linoleic and oleic acids using 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide. The isotopic purity was found to be satisfactory by mass spectrometry, and nuclear magnetic resonance properties of the new compounds were tabulated. The labeled compounds can be used as internal standards in liquid chromatography/mass spectrometry assays for clinical and biochemical studies.
Abbreviations mp, melting points; 1 H-NMR, proton nuclear magnetic resonance; DEPT,distortionless enhancement by polarization transfer; EI, Electron ionization, LR-MS, low-resolution mass spectra; HR-MS, high-resolution mass spectra; EI, electrospray ionization; DMAP, N,N'-dimethylaminopyridine; THF, tetrahydrofuran; rDA, retro Diels-Alder; EDCI, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide
Introduction
Cholesterol is a critical component of cell membranes and lipoproteins, and is a precursor for steroid hormones, bile acids and vitamin D. Free cholesterol and cholesteryl esters in plasma are incorporated into lipoproteins containing phospholipids and other lipids as well as apolipoproteins. In recent years, attention has been paid to pharmacokinetics of cholesteryl esters since high levels of cholesteryl esters cause atherosclerosis and since the cholesterol ester transfer protein is a target of drugs aimed to increase high-density lipoprotein cholesterol.
In clinical laboratories, the serum concentration of cholesteryl ester is determined by subtracting the free cholesterol from the total cholesterol [1] . This assay measures only total and free cholesterol, instead of the cholesterol ester itself directly, and gives no information of fatty acid composition. The fatty acid profile is variable in cholesteryl esters in human serum in terms of carbon chain length, and number and location of double bond, and the degree of oxidation. It is possible that the pathophysiological significance of individual cholesterol esters is not identical. Also, it is difficult to measure trace amounts of cholesteryl esters in culture media or body fluids other than plasma because of the low sensitivity of enzymatic methods. Therefore, a sensitive and specific assay for various species of cholesteryl esters is required in lipid metabolism research.
Liquid chromatography/mass spectrometry (LC/MS) analysis with a stable isotope-labeled internal standard is superior to the enzymatic method in molecular information and sensitivity. LC/MS is reported to be useful in the measurement of various lipid molecules at low levels [2] [3] [4] . The accurate analysis of trace lipids in complex biological matrices requires the use of reliable standards, which are often unavailable. Table 1 . Electron ionization (EI) low-resolution mass spectra (LR-MS) and high-resolution mass spectra (HR-MS) were obtained by JMS-T100GCv (JEOL Ltd., Tokyo, Japan) in positive-ion mode. The LC-electrospray ionization (ESI)/MS analyses were carried out using a LTQ XL Orbitrap mass spectrometer (Thermo Scientific, Bremen, Germany) equipped with an ESI source and coupled to a Surveyor MS pump (Thermo Scientific, Bremen, Germany) in positive-ion detection. The mass spectra were obtained in Fourier transform mode and were calibrated with a polytyrosine as a standard.
Mass spectra were acquired with a target mass resolution of R = 60,000 at m/z 400 under automatic gain control set to 5.0 × 10 5 as the target value. The ion-spray potential was set at 5.0 kV in positive-ion mode with a scan range of m/z 150-1,000. The trap fill-time was set at 500 ms. Nitrogen was used as sheath gas (set at 50 arbitrary units To a stirred solution of 1b (3 g, 5.55 mmol) in dry tetrahydrofuran (THF, 50 ml) was added borane dimethyl sulfide (2.6 ml, 27.4 mmol) at ice temperature under a gentle stream of Ar gas, and the mixture was stirred for 2 h at ice temperature and then for 4 h at room temperature. After being cooled in ice bath, a solution of 30% H 2 O 2 (25 ml)-10% NaOH (25 ml) was carefully added to the solution and the reaction mixture was stirred for 1 h at ice temperature. The resulting solution was extracted with EtOAc (1 × 120 ml). The combined extracts was washed successively with 5% NaHSO 3 (1 × 60 ml), 5% NaHCO 3
(1 × 60 ml), and saturated brine (1 × 60 ml), dried over anhydrous Na 2 SO 4 , and evaporated to dryness. Recrystallization of the product from MeOH gave 2 as colorless needles: yield 83% 
5α-cholest-2-en-6-one (4)
A solution of 3 (500 mg, 0.900 mmol) in γ-collidine (6 ml) was refluxed for 2 h. The resulting solution was diluted with EtOAc (20 ml), washed with 5% HCl (1 × 10 ml), 5% 
Epoxidation of 4 with m-chloroperbenzoic acid
To a solution of 4 (70 mg, 0.182 mmol) in EtOAc (5 ml) was added m-chloroperbenzoic acid (130 mg, 0.753 mmol), and the mixture as stirred for 4 h at room temperature. The resulting solution was diluted with EtOAc (10 ml), washed successively with 5% NaHSO 3
(1 × 5 ml), 5% NaHCO 3 (1 × 5 ml), and H 2 O (1 × 5 ml), dried over anhydrous Na 2 SO 4 , and evaporated to dryness. The product was subjected to column chromatography on silica gel with n-hexane-EtOAc (15:1, v/v) as an eluent. Recrystallization of a less polar effluent peak from MeOH gave 2β,3β-epoxy-5α-cholestan-6-one (6) 
Reduction of 7 with LiAlH 4
A solution of 7 (20 mg, 0.050 mmol) and LiAlH 4 (27 mg, 0.711 mmol) in dry THF (15 ml) was refluxed for 4 h. After careful addition of H 2 O to decompose the excess reagent, the resulting solution was extracted with EtOAc (1 × 10 ml). The extracts was successively washed with 5% HCl (1 × 5 ml), 5% NaHCO 3 (2 × 5 ml), and saturated brine (1 × 5 ml), and dried over anhydrous Na 2 SO 4 . After evaporation of the solvent under reduced pressure, the product was submitted to column chromatography on silica gel with n-hexane-EtOAc 
5α-cholestane-3,6-dione (9a)
To a solution of 8a (15 mg, 0.037 mmol) in acetone (4 ml) was added Jones' reagent (0.1 ml), and the mixture was stirred at room temperature for 5 min. After addition of 2-propanol to decompose the excess reagent, the resulting solution was diluted with EtOAc (10 ml), washed with 5% NaHCO 3 (2 × 5 ml) and H 2 O (1 × 5 ml), dried over anhydrous 
3β,6β-dihydroxy-5α-cholestane (10a)
To a solution 9a (20 mg, 0.050 mmol) in THF (3 ml)-MeOH (12 ml) was added NaBH 4 (10 mg, 0.264 mmol), and the mixture was stirred 30 min at room temperature. After careful addition of 8.3% HCl to decompose the excess reagent, the organic solvent was evaporated under reduced pressure. The residue was diluted with EtOAc (10 ml), washed successively with H 2 O (1 × 5 ml), 5% NaHCO 3 (1 × 5 ml), and saturated brine (1 × 5 ml), dried over anhydrous Na 2 SO 4 , and evaporated to dryness. Purification of the product by column chromatography on silica gel with n-hexane-EtOAc 
3β-tert-Butyldimethylsilyloxy-6β-hydroxy-5α-cholestane (10b)
To a solution of 10a (400 mg, 0.988 mmol) in dry N,N'-dimethylformamide (DMF, 4 ml)-dry pyridine (2 ml) were added imidazole (340 mg, 4.99 mmol) and tert-butyldimethylsilyl chloride (TBDMSCl, 600 mg, 3.98 mmol), and the mixture was stirred overnight at room temperature. The resulting solution was diluted with EtOAc (20 ml),
washed with H 2 O (2 × 10 ml), dried over anhydrous Na 2 SO 4 , and evaporated to dryness.
Purification of the product by column chromatography on silica gel with n-hexane-EtOAc 
Dehydration 10b with POCl 3
To a solution of 10b (18 mg, 0.035 mmol) in dry pyridine (0.5 ml) was added POCl 3
(170 mg, 1.11 mmol), and the mixture was stirred overnight at room temperature. After careful addition of H 2 O at ice temperature to decompose the excess reagent, the resulting solution was diluted with EtOAc (10 ml), washed with 10% AcOH (1 × 5 ml), 5% NaHCO 3
(1 × 5 ml), and H 2 O (1 × 5 ml), dried over anhydrous Na 2 SO 4 , and evaporated to dryness. The compound 8b (228 mg, 0.561 mmol) was oxidized with Jones' reagent (2 ml) in acetone (20 ml) for 5 min at room temperature as described for preparation of 9a. After processing in analogous manner, the resulting (2β-2 H)-3,6-diketone (9b), without purification, was reduced with NaBD 4 (73 mg, 1.75 mmol) in THF (8 ml)-MeOH (12 ml) for 1 h at room temperature as described for preparation of 10a. After being processed in analogous manner, the resulting (2β,3α,6-2 H 3 )-3β,6β-dihydroxy-5α-cholestane (10c), without purification,t was silylated with imidazole (340 mg, 4.99 mmol) and TBDMSCl (600 mg, 3.98 mmol) in dry DMF (4 ml)-dry pyridine (2 ml) for 12 h at room temperature as described for preparation of 10b. After being processed in analogous manner, the crude product was subjected to column chromatography on silica gel with n-hexane-EtOAc in dry pyridine (9 ml) overnight at room temperature as described for preparation of 11a.
After being processed in an analogous manner, the product was subjected to column chromatography on silica gel with n-hexane-EtOAc (40:1, v/v) as an eluent. 
Recrystallization of a homogenous effluent from

(2β,3α,6-2 H 3 )-3β-hydroxycholest-5-ene (11c)
The compound 11b (130 mg, 0.258 mmol) was treated with 5% HCl (0.4 ml) in acetone (6 ml) for 45 min at room temperature. After evaporation of acetone under reduced pressure, the residue was diluted with EtOAc (10 ml), washed with 5% NaHCO 3 ( 
(2β,3α,6-2 H 3 )-3β-acetoxycholest-5-ene (11d)
The compound 11c (10 mg, 0.026 mmol) was acetylated with acetic anhydride (0.4 ml) in dry pyridine (0.5 ml) for 17 h at room temperature. After addition of H 2 O, the resulting solution was extracted with EtOAc (1 × 10 ml). The organic layer was successively washed with 5% HCl (1 × 5 ml), 5% NaHCO 3 (2 × 5 ml), and H 2 O (1 × 5 ml), dried over anhydrous 
(2β,3α,6-2 H 3 )cholesteryl linoleate (12a)
To a solution of 11c (210 mg, 0.539 mmol) in dry CH 2 Cl 2 (5 ml) were added linoleic acid (271 mg, 0.966 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDCI, 210 mg, 1.350 mmol), and DMAP (20 mg, 0.164 mmol), respectively, and the mixture was stirred overnight at room temperature. After evaporation of the solvent under reduced pressure, the residue was diluted with EtOAc (10 ml), washed with 5% HCl (1 × 5 ml), 5% NaHCO 3 (2 × 5 ml), and H 2 O (1 × 5 ml), dried over anhydrous Na 2 SO 4 , and evaporated to dryness.
Purification of the product by column chromatography on silica gel with n-hexane-benzene (M-NH 4 -NH 3 -oleic acid). Moreover, the deuterium atoms labeled in fatty acid or cholesterol side chain are labile thorough the cholesterol metabolic process, making them unsuitable for biochemical studies.
Results and Discussion
In contrast, the deuterated atoms in the steroid ring are more stable metabolically.
Furthermore, too many deuterated compounds might behave a different way from the analytes for the isotope effect on HPLC separation [19, 20] . As an alternative approach toward the final goal, we undertook to introduce three nonexchangeable deuterium atoms at 2β, 3α, and C-6 position of cholesteryl linoleate and cholesteryl oleate.
As a preliminary experiment toward the final goal, we sought to establish a synthetic route by which the label could be unambiguously introduced at the desired position. Of the numerous deuteration methods so far available, the reductive cleavage of epoxide with lithium aluminum deuteride (LiAlD 4 ) and reduction of ketone with sodium borodeuteride (NaBD 4 ) or LiAlD 4 appeared to be favorable for the present purpose. Additionally, it is well known that opening the oxide ring of 2α,3α-epoxy-5α-steroids with LiAlH 4 yields predominantly 3α-hydroxy-5α-steroids [21] and reduction of 3,6-diketo-5α-steroids with sterically less demanding hydride using NaBH 4 yields predominantly 3β,6β-diol [22] . Moreover, it is sufficiently substantiated that dehydration of the 6β-hydroxy-5α-steroid with phosphorus oxychloride (POCl 3 ) proceeds regiospecifically to give 5-dehydrated steroid in an excellent yield [10, 15, 23] . We therefore, prepared 2α,3α-epoxy-5α-cholestan-6-one (7) as the key intermediate (Fig.1) .
Hydroboration of cholesteryl tosylate (1b), which is readily obtainable from cholesterol (1a), and subsequent oxidation of the organoborane with alkaline hydrogen peroxide followed by oxidation of the resulting 6α-hydroxy-3β-tosylate (2) with Jones' reagent furnished the 6-ketone (3) in a high yield. Subsequently, elimination of the oxygen function at C-3 was effected by refluxing in γ-collidine yielding the ∆ 2 -olefin (4) accompanied with a small amount of ∆ 4 -6-ketone (5) whose separation was readily attained by column chromatography on silica gel. The attack of m-chloroperbenzoic acid toward 4 did take place mainly from the less hindered α-side to afford the desired 2α,3α-epoxide (7) as a major product accompanied with a small amount of the 2β,3β-epoxide (6). Reductive cleavage of 2α,3α-oxido ring and reduction of the carbonyl group at C-6 position with LiAlH 4 was then carried out simultaneously. As expected, the trans-diaxial opening of the oxide ring and attack of hydride toward the carbonyl group from α-side occurred to give the 3α,6β-diol (8a) as the major product accompanied with a small amount of 3α,6α-diol whose separation was easily attained by column chromatography on silica. The structural assignment of the 3α,6β-diol was rationalized by inspection of the 1 H-NMR spectrum where multiplet signals due to the equatrial 3β-H and 6α-H at 4.01-4.04 ppm and 3.62-3.679 ppm were observed. Here, inversion of the 3α-hydroxyl to 3β-hydroxyl is required to obtain the targeted compound.
Therefore, we attempted oxidation of 8a with Jones' reagent followed by NaBH 4 reduction of the resulting 3,6-diketone (9a) to afford 3β,6β-dihydroxy derivative (10a). It has previously been demonstrated that the 6β-hydroxy group is not susceptible to tert-butyldimethylsilylation due to steric hindrance [10, 15] . Accordingly, the 3β,6β-diol was treated with tert-butyldimethylsilyl chloride and imidazole in the usual manner to afford the 3-monosilyl ether (10b) in a fairly good yield. After treating with POCl 3 in pyridine, 10b was dehydrated to yield cholesterol tert-butyldimethylsilyl ether (11a), which can be readily converted to cholesterol by acid hydrolysis. The synthetic route thus established is promising to introduce the deuterium stereospecifically into the 2β, 3α, and C-6 positions of cholesterol.
The preparation of 2β-deuterated-3α-ol (8b) was then attained by trans-diaxial opening of the 2α,3α-epoxide (7) with LiAlD 4 . The compound 8b was converted to the 2β-d 1 -3,6-diketone (9b) by oxidation with Jones' reagent. Subsequent reduction of compound 9b with NaBD 4 , followed by silylation of the resulting (2β,3α,6-2 H 3 )3β,6β-diol (10c) afforded the (2β,3α,6-2 H 3 )3β,6β-diol 3-monosilyl ether (10d). Dehydration of the 6β-hydroxyl function in 10d with POCl 3 in pyridine yielded solely the ∆
5
-unsaturated compound (11b). Being subjected to desilylation, 11b was transformed into the desired (2β,3α,6-2 H 3 )cholesterol.
The structure of the obtained deuterated cholesterol was confirmed by 1 H-NMR along with positive-ion EI-MS spectrum. at m/z 389 as the base peak which was shifted were also observed. In addition, the most typical fragments in the MS spectrum of (2β,3α,6-2 H 3 )cholesteryl acetate is that derived by the loss of acetic acid at m/z [M-60], a classical McLafferty rearrangement [24] (Fig. 2) involving the stereospecific elimination of a hydrogen atom at 2α position. One of the well-known mechanisms of ion fragmentation is the so-called retro Diels-Alder (rDA) reaction that yields a diene and an olefin. We believe that the rDA reaction produces not 
